{
    "2019-09-19": [
        [
            {
                "time": "2023-10-05",
                "original_text": "5 Companies Growing Earnings",
                "features": {
                    "keywords": [
                        "Companies",
                        "Growing",
                        "Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pfizer Is Spinning Off Upjohn. Whatâ€™s Left Will Be No Bargain, Analyst Says",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Spinning",
                        "Off",
                        "Upjohn",
                        "Analyst",
                        "Bargain"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Scientific",
                        "Advancements",
                        "Cancer",
                        "Care",
                        "ESMO",
                        "Congress",
                        "Expanded",
                        "Portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}